Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hematopoietic and Lymphatic System Neoplasm × Bupropion × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lung Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Specimen Handling 2 Triptorelin Pamoate 1 Standard of Care 1 Practice Guidelines as Topic 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03996265 2026-01-15

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

University of Rochester

Phase 3 Active not recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡